Company news

EMV Capital PLC news in 2021

EMV Capital PLC's news releases, calls and decks from 2021, newest first.

View company

Issue of Equity

December 29, 2021

TR-1: Form for notification of major holdings

December 21, 2021

Q-Bot Investment and Share Acquisition

December 21, 2021

Acquisition of majority stake in Cetromed

December 20, 2021

Martlet Capital Update

December 13, 2021

PDS Phase 2 Clinical Trial Update

December 6, 2021

$1million investment in portfolio company, EpiBone

November 26, 2021

PDS Reports Q3 2021 Results & Business Update

November 10, 2021

Sofant Signs EUR7.3m ESA Contract

November 4, 2021

PDS to License Novel Proteins for Flu Vaccine

November 1, 2021

EMV Capital Participates in £843k Sofant Funding

October 26, 2021

ProAxsis announces the approval of a key US patent

October 22, 2021

Investor Presentations

October 4, 2021

Grant of Options to Directors

September 29, 2021

Notice of Results and Analyst Briefing

September 20, 2021

Investment in Martlet Capital Limited

September 16, 2021

Result of General Meeting, TVR & PDMR Dealings

June 28, 2021

PDS Announces Closing of c. $52m Public Offering

June 22, 2021

NSCI Participates in $45m PDS Equity Issue

June 16, 2021

PDS announces proposed offering of common stock

June 15, 2021

Proposed Placing

June 10, 2021

PDS Announces Release of PDS0101 Interim Data

June 8, 2021

PDS Announces Release of PDS0101 Abstract

May 20, 2021

PDS receives $4.5m from net sale of tax benefits

May 18, 2021

PDS Reports Results for Q1 2021 & Business Update

May 13, 2021

PDS Announces Presentation at ASCO Annual Meeting

April 30, 2021

EMV Capital Advises on £740k Fundraise for Sofant

April 28, 2021

Preliminary Results for the year ended 31 Dec 2020

March 31, 2021

PDS Reports Results for FY2020 & Business Update

March 18, 2021

$60m Commitment for PDS Vaccine Consortium

March 11, 2021

PDS Biotech Consortium Update

February 23, 2021

PDS Phase II Trial Update & Restoration of Trading

February 3, 2021

Suspension of Trading on AIM

February 2, 2021

Issue of Shares, Director/PDMR Shareholding & TVR

January 25, 2021

Calls in 2021

Decks in 2021